Charles H. Weaver, MD

November 17, 2017

A New Option for High-risk Multiple Myeloma?

Charles H. Weaver, MD
November 15, 2017

Seattle Genetics Announces FDA Approval of Adcetris for Cutaneous TCell Lymphoma

Charles H. Weaver, MD
November 6, 2017

Answers to FAQ’s About Cardura®

Charles H. Weaver, MD
November 1, 2017

Nexavar® Effective in Elderly Patients with Kidney Cancer

Charles H. Weaver, MD
October 31, 2017

Erythropoietin Plus Granulocyte Macrophage Factor for Myelodysplastic Syndrome

Charles H. Weaver, MD
October 18, 2017

Heavy Doses Of Vitamin B Supplements May Increase Lung Cancer Risk

Charles H. Weaver, MD
October 16, 2017

Targeting BRAF and EGFR Doubles Progression-free Survival in Colorectal Cancer

Charles H. Weaver, MD
October 11, 2017

Faith and Cancer

Charles H. Weaver, MD
September 28, 2017

Antidepressants May Reduce Colorectal Cancer Risk

Charles H. Weaver, MD
September 4, 2017

Radiofrequency Ablation an Effective Alternative to Surgery in Renal Cell Cancer

Charles H. Weaver, MD
September 1, 2017

FDA Approves First Gene Therapy

Charles H. Weaver, MD
August 22, 2017

Besponsa for B-cell Acute Lymphoblastic Leukemia

Charles H. Weaver, MD